Tag: pharmaceuticals
-
Report: 19 New Precision Medicines Approved in 2017
A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals.
-
Microsoft Providing A.I. for Big Data Cancer Research
Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp.
-
Grants Made to Commercialize Bone, Cancer Research
A program supporting research with commercial potential awarded grants to scientists studying stem cells for bone grafts, treatments for melanoma, and protein therapies for cancer that change gene expression patterns.
-
Sanofi Buys Nano-Antibody Biotech in $4.8B Deal
Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion.
-
Biotech, Pharma Dominate U.S. Academic Patents
In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total.
-
Overlooked Drugs Show Promise Against Superbugs
A class of antibiotics first discovered in the 1970s, but passed by as new drugs came on the market, are getting a second look as the need intensifies for better weapons to treat infections resistant to most antibiotics.
-
Vaccine Shown Effective Against Range of Flu Viruses
An experimental vaccine made with protein-infused nanoscale particles was shown to provide long-lasting protection in lab mice against a broad range of common influenza viruses.
-
Agencies Send Warnings to Halt Opioid Cessation Scams
Two federal agencies sent warning letters to companies the agencies say are illegally marketing products making false or unsubstantiated claims about their treating opioid addiction or withdrawal.
-
T-Cell Therapy Company Gains $100M in Venture Funds
A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round.
-
Blood Disorder Drug Maker Acquired in $11.6B Deal
The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders.